McKesson Corporation (NYSE:MCK) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 31, 2017, Patrick J. Blake resigned as Executive Vice President and Group President of McKesson Corporation (the “Company”). Mr. Blake was identified as a “named executive officer” in the Company’s 2016 definitive proxy statement, which was filed with the Securities and Exchange Commission on June 17, 2016. While he no longer will serve as an executive officer, Mr. Blake will continue to assist in the evaluation of strategic alternatives for the Company’s Enterprise Information Solutions business.
About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology. McKesson Corporation (NYSE:MCK) Recent Trading Information
McKesson Corporation (NYSE:MCK) closed its last trading session up +0.06 at 144.84 with 1,027,914 shares trading hands.
